Preclinical Models for Drug Development
In December 2016 the Institute for Medical Research hosted a three-day workshop on preclinical models for drug development, with a visiting speaker from Memorial Sloan Kettering Cancer Center, New York.
· Workshop · Supported by Prima Nexus
A three-day workshop at IMR
The Molecular Pathology Unit of the Institute for Medical Research (IMR) organised the workshop from 5 to 7 December 2016 in Meeting Room 2 (BM2) at IMR, Kuala Lumpur. Sessions ran from 8.30am to 4.30pm each day. The Ministry of Science, Technology and Innovation (MOSTI) supported the workshop with the Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm). The invitation noted that seats were limited.
The speaker and the programme
The visiting speaker was Dr Elisa de Stanchina, head of the Antitumor Assessment Core Facility at Memorial Sloan Kettering Cancer Center in New York. Her facility was set up in 2003 to support the early discovery of cancer drugs. It works with investigators to set up mouse models, to design and run pharmacokinetic, toxicity and efficacy studies, and to choose the best formulation, route and treatment schedule for each new compound, alone or in combination with other agents. One talk covered testing drug combinations to overcome resistance to B-Raf inhibitors.
Prima Nexus's part
Prima Nexus supported the workshop. Researchers now planning preclinical work in animal models can read how Prima Nexus supports these studies on our animal studies page.
More of our work with IMR.
Read the story: Prima Nexus supported two drug development workshops in 2016, at UCSI University and IMR.
About Prima Nexus
Founded in 2014, Prima Nexus Sdn Bhd is a Malaysian research, scientific consulting and integrated research support company advancing scientific discovery and healthcare innovation. We provide end-to-end research solutions, from early-stage discovery and experimental design to cell-based studies, preclinical animal testing, clinical trials and commercialization. Our multidisciplinary expertise spans genomics, genetic applications, proteomics, molecular biology, stem cell research, bioinformatics and clinical research. Through strategic collaborations with universities, research institutions, industry and global technology partners, we connect scientific expertise and advanced technologies to accelerate research into real-world applications. We also run hands-on training for researchers across Malaysia. More about Prima Nexus.
